These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26278421)

  • 1. Validity of the Hochberg procedure revisited for clinical trial applications.
    Huque MF
    Stat Med; 2016 Jan; 35(1):5-20. PubMed ID: 26278421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of multiplicity adjustment strategies for correlated binary endpoints.
    Leon AC; Heo M
    J Biopharm Stat; 2005; 15(5):839-55. PubMed ID: 16080237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symmetric graphs for equally weighted tests, with application to the Hochberg procedure.
    Xi D; Bretz F
    Stat Med; 2019 Nov; 38(27):5268-5282. PubMed ID: 31657025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A group sequential Holm procedure with multiple primary endpoints.
    Ye Y; Li A; Liu L; Yao B
    Stat Med; 2013 Mar; 32(7):1112-24. PubMed ID: 23239078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procedures for two-sample comparisons with multiple endpoints controlling the experimentwise error rate.
    Lehmacher W; Wassmer G; Reitmeir P
    Biometrics; 1991 Jun; 47(2):511-21. PubMed ID: 1912258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods for the analysis of multiple endpoints in small populations: A review.
    Ristl R; Urach S; Rosenkranz G; Posch M
    J Biopharm Stat; 2019; 29(1):1-29. PubMed ID: 29985752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified truncated Hochberg procedure for multiple endpoints: An application in a confirmatory trial for pediatric functional constipation.
    Chen J; Thakur M; Zeng H; Gabriel A
    Contemp Clin Trials; 2023 Jun; 129():107185. PubMed ID: 37059263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of gatekeeping and other testing methods for identifying superior drug combinations in bifactorial designs with isotonic parameters.
    Soulakova JN
    J Biopharm Stat; 2011 Jul; 21(4):635-49. PubMed ID: 21516561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weighted multiple testing correction for correlated tests.
    Xie C
    Stat Med; 2012 Feb; 31(4):341-52. PubMed ID: 22114000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Dunnett-Bonferroni-based parallel gatekeeping procedure for dose-response clinical trials with multiple endpoints.
    Xu H; Nuamah I; Liu J; Lim P; Sampson A
    Pharm Stat; 2009; 8(4):301-16. PubMed ID: 19065544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical planning in confirmatory clinical trials with multiple treatment groups, multiple visits, and multiple endpoints.
    Sun H; Snyder E; Koch GG
    J Biopharm Stat; 2018; 28(1):189-211. PubMed ID: 28992425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constructing multiple test procedures for partially ordered hypothesis sets.
    Edwards D; Madsen J
    Stat Med; 2007 Dec; 26(28):5116-24. PubMed ID: 17476650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On generalized fixed sequence procedures for controlling the FWER.
    Qiu Z; Guo W; Lynch G
    Stat Med; 2015 Dec; 34(30):3968-83. PubMed ID: 26228241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiplicity adjustment for multiple endpoints in clinical trials with multiple doses of an active treatment.
    Quan H; Luo X; Capizzi T
    Stat Med; 2005 Jul; 24(14):2151-70. PubMed ID: 15909290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptive extensions of a two-stage group sequential procedure for testing primary and secondary endpoints (II): sample size re-estimation.
    Tamhane AC; Wu Y; Mehta CR
    Stat Med; 2012 Aug; 31(19):2041-54. PubMed ID: 22733687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of multiple intersection-union tests for multiple endpoints in combination therapy trials.
    Westfall PH; Ho SY; Prillaman BA
    J Biopharm Stat; 2001; 11(3):125-38. PubMed ID: 11725927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A note on the power of Fisher's least significant difference procedure.
    Meier U
    Pharm Stat; 2006; 5(4):253-63. PubMed ID: 17128424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mixture gatekeeping procedure based on the Hommel test for clinical trial applications.
    Brechenmacher T; Xu J; Dmitrienko A; Tamhane AC
    J Biopharm Stat; 2011 Jul; 21(4):748-67. PubMed ID: 21516567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in p-Value Based Multiple Test Procedures.
    Tamhane AC; Gou J
    J Biopharm Stat; 2018; 28(1):10-27. PubMed ID: 29072552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The issue of multiplicity in noninferiority studies.
    Ke C; Ding B; Jiang Q; Snapinn SM
    Clin Trials; 2012 Dec; 9(6):730-5. PubMed ID: 22879575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.